MENU
SWTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

SpringWorks Therapeutics (SWTX) Earnings Date & Reports

SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing, and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer... Show more

A.I. Advisor
published Earnings

SWTX is expected to report earnings to fall 32.96% to -74 cents per share on July 30

SpringWorks Therapeutics SWTX Stock Earnings Reports
Q2'25
Est.
$-0.74
Q1'25
Missed
by $0.34
Q4'24
Missed
by $0.39
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.58
The last earnings report on May 29 showed earnings per share of -111 cents, missing the estimate of -76 cents. With 4.05M shares outstanding, the current market capitalization sits at 3.53B.
View a ticker or compare two or three
SWTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which focuses on developing drugs for underserved patient populations suffering from devastating rare diseases and cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
100 Washington Boulevard
Phone
+1 203 883-9490
Employees
305
Web
https://www.springworkstx.com